This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03395/identifier/bindingdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03395/identifier/kegg-compound/
n6http://linked.opendata.cz/resource/drugbank/drug/DB03395/identifier/pubchem-compound/
n11http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB03395/identifier/kegg-drug/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03395/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB03395/identifier/drugbank/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03395
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB03395 n14:DB03395
dcterms:title
Enalkiren
adms:identifier
n6:60594 n7:46505948 n8:C07466 n9:D03738 n12:50006202 n13:DB03395
n3:IUPAC-Name
n4:271B4404-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B440A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4409-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4406-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4407-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4408-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4402-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4400-363D-11E5-9242-09173F13E4C5 n4:271B4403-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4401-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4410-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4411-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B440B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B440C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B440E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B440D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B440F-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
113082-98-7
n3:Bioavailability
n4:271B4416-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4418-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4419-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4415-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4414-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4417-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4405-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4412-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4413-363D-11E5-9242-09173F13E4C5